Publication | Open Access
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults
42
Citations
16
References
2016
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1